Marketers need to dig deeper to facilitate communications that are dynamic enough to reach and engage patients on a more personal, emotional level.

U.S. Attorney General Jeff Sessions will unveil a major crackdown on healthcare fraud involving opioid treatment programs, Bloomberg News reported, citing two people familiar with the matter.

The white paper explores trends and market forces affecting organized provider groups (OPGs) and identifies opportunities for pharmaceutical manufacturers to partner with OPGs to develop mutually beneficial programs addressing areas of shared interest.

A bill passed by U.S. House Republicans would cause 23 million people to lose healthcare coverage by 2026 while de-stabilizing health insurance markets in some states and making it hard for sick people to buy insurance, a budget watchdog agency said.

It’s easy for politicians and consumers to rage about the high price of prescription drugs, but Wayne Winegarden, Pacific Research Institute’s senior fellow in business and economics, said those prices are not to blame for the high cost of healthcare in the United States.

The U.S. House of Representatives narrowly approved a bill to repeal Obamacare, handing Republican President Donald Trump a victory that could prove short-lived as the healthcare legislation heads into a likely tough battle in the Senate.

Republicans in the U.S. House of Representatives predicted victory in a planned voteto repeal Obamacare that would take a step toward achieving their seven-year quest to replace the healthcare law and hand President Donald Trump a major legislative victory.

President Donald Trump and his aides courted moderate Republican lawmakers on a proposal to overhaul the U.S. healthcare system as the White House struggled to avoid another embarrassing defeat on a top legislative priority.

The head of the U.S. House of Representatives Freedom Caucus said Republicans still lack the votes to pass a reform bill to overhaul the U.S. healthcare system.

Habit and red tape are not sufficient excuses for life sciences organizations to keep doing things the way they always have.